A recent survey by the American Academy of Dermatology showed that only 13% of Americans plan to use sun protection when going for walks or hikes in cold weather.
Not a small number of people believe that sun protection is needed only during the warm weather months. especially at the beach.
They are mistaken, according to a news release from the American Academy of Dermatology (AAD)
“Many people don’t realize that you need to use sun protection in the winter,” said Dawn Davis, M.D., a dermatologist and professor of dermatology at Mayo Clinic Rochester, said in the news release. “It’s easy to get sunburned during colder months because snow reflects the sun’s damaging rays.”
A recent AAD survey showed that only 13% of Americans plan to use sun protection when going for walks or hikes in cold weather. Even fewer — 4%— plan for it when shoveling snow, and only 6% during outdoor games, exercise or sports in cold weather. According to the survey, just 1 in 7 Americans are unaware that the sun’s ultraviolet rays are reflected by snow, water and sand.
Skin cancer is one of the most common yet preventable forms of cancer, according to the news release. At least 1 in 5 Americans will develop skin cancer during their lifetime and exposure to ultraviolet light from the sun is the most modifiable risk factor for skin cancer, including melanoma, the deadliest form of skin cancer. According to the American Cancer Society, invasive melanoma accounts for only 1% of all skin cancer cases but the majority of deaths. The society projects that in 2024, an estimated 100,640 new cases of invasive and 99,700 cases of in situ melanoma will be diagnosed in the U.S. and almost 8,300people will die from the disease.
Davis’ recommendations for reducing sun exposure include seeking shade between 10 a.m. and 2 p.m., wearing sun-protective clothing (long-sleeved shirts, wide-brimmed hats, sunglasses) and applying broad-spectrum, water-resistant sunscreen with an SPF rating of 30 or higher to all skin not covered by clothing.
Insights Into Chronic Itch From Shawn Kwatra, M.D.
April 15th 2025A Q&A between Shawn Kwatra, M.D., professor and chair of dermatology at the University of Maryland School of Medicine, and Managed Healthcare Executive about new discoveries in chronic itch, how treatment options are improving and the challenges patients face in getting access to the right therapies.
Read More
Phase 3 Trials of Oral Povorcitinib Show Positive Results in Hidradenitis Suppurativa
March 24th 2025A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with moderate to severe hidradenitis suppurativa, a chronic and painful inflammatory skin condition.
Read More
Opzelura Topical Cream Drives Incyte's Record Growth in 2024 with 50% Revenue Surge
February 18th 2025Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S. that helps restore skin color for this condition. It’s also approved to treat mild to moderate atopic dermatitis in patients 12 and older who are not immunocompromised.
Read More